XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2022
Oct. 02, 2021
Oct. 01, 2022
Oct. 02, 2021
Condensed Consolidated Statements of Income        
Revenues $ 269,817 $ 184,831 $ 766,781 $ 512,180
Cost of revenues 104,232 75,322 281,521 214,619
Gross profit 165,585 109,509 485,260 297,561
Operating expenses:        
Research and development 84,624 72,656 245,677 201,503
Selling, general and administrative 50,738 46,128 144,398 131,535
Operating expenses 135,362 118,784 390,075 333,038
Operating income (loss) 30,223 (9,275) 95,185 (35,477)
Other income (expense):        
Interest income and other, net 4,672 1,476 9,616 3,100
Interest expense (1,527) (6,595) (4,874) (24,405)
Income (loss) from continuing operations before income taxes 33,368 (14,394) 99,927 (56,782)
Provision for income taxes 14,188 9,386 36,871 12,543
Equity-method earnings 1,819 4,040 2,985 5,938
Income (loss) from continuing operations 20,999 (19,740) 66,041 (63,387)
Income from discontinued operations, net of income taxes   2,106,796   2,183,884
Net income $ 20,999 $ 2,087,056 $ 66,041 $ 2,120,497
Basic earnings (loss) per share:        
Continuing operations $ 0.62 $ (0.45) $ 1.84 $ (1.44)
Net income 0.62 48.11 1.84 48.08
Diluted earnings (loss) per share:        
Continuing operations 0.60 (0.45) 1.79 (1.44)
Net income $ 0.60 $ 46.76 $ 1.79 $ 46.71
Weighted-average common shares outstanding:        
Basic 34,079 43,385 35,935 44,103
Diluted 34,779 44,634 36,968 45,394